Patients with active Cushing’s disease have lower blood levels of irisin, a hormone secreted by muscle cells, than those with controlled disease and healthy people, a study has found. Thus, measuring the levels of irisin may become a marker for diagnosing impairments of bone, muscle, and fat (adipose) tissues in this patient population, researchers suggest. Such a marker would be helpful for identifying a condition called sarcopenia — characaterized by muscle weakness and loss —…

You must be logged in to read/download the full post.